with micro spheres
learn more about radioembolisation
Hepatocarcinoma is the most common primary tumour in the liver. It's the fifth leading cause of death for cancer in the world and is very frequent in Spain: between 5,000 and 8,000 patients contract it every year. The Clínica Universidad de Navarra has more than 25 years' experience in the treatment of this tumour and we are leaders in investigation in this area.
Nowadays, we have a wide variety of treatments: hepatic transplant, liver resection surgery, chemoembolization, radioembolisation or more simple techniques, like radiofrequency ablation. In the past two or three years we have also had drugs available which are capable of acting systematically against specific stages of the disease.
- Sometimes, a small number of micro spheres can go to other parts of the body like the gallbladder, stomach or lung. If this occurs, it can cause an inflammation in these areas and it would be necessary to administer additional treatment.
- Although this complication is rare (occurring in only 5% of cases), certain patients' liver can be especially sensitive to the effect of the radiation and may develop hepatitis or jaundice.